S25-418 Novel Dual Chelator Targeted Radioligand Therapy of Metastatic Castration Resistant Prostate Cancer (mCRPC) Metastatic castration resistant prostate cancer (mCRPC) is an advanced stage of prostate cancer managed with a combination of various therapeutics. Hong Song Arutselvan Natarajan